ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gefitinib API Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38Y7314
Home | Market Reports | Business & Industrial| Chemicals Industry
Global and Japan Gefitinib API Market Insights Forecast to 2027
BUY CHAPTERS

Global Gefitinib API Market Research Report 2025

Code: QYRE-Auto-38Y7314
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Scion Pharm Taiwan
Farmhispania Group
Chem Genix
Jeil pharmaceutical
Zhuhai Rundu Pharma
Cipla Ltd
Brawn Laboratories
Nischem International
Zhejiang Hisun Pharmaceutical
Qilu Pharmaceutial

Gefitinib API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gefitinib API Market

Gefitinib API Market

The global market for Gefitinib API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is a white powder with anti - tumor and anti - mitosis effect. The molecular formula is C22H24ClFN4O3, CAS number is 184475-35-2.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gefitinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gefitinib API.
The Gefitinib API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gefitinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gefitinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gefitinib API Market Report

Report Metric Details
Report Name Gefitinib API Market
CAGR 5%
by Type
  • Purity ≥ 98 %
  • Purity ≥ 99 %
by Application
  • Gefitinib Tablets
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Scion Pharm Taiwan, Farmhispania Group, Chem Genix, Jeil Pharmaceutical, Zhuhai Rundu Pharma, Cipla, Brawn Laboratories, Nischem International, Zhejiang Hisun Pharmaceutical, Qilu Pharmaceutial
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gefitinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Gefitinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Gefitinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gefitinib API Market report?

Ans: The main players in the Gefitinib API Market are Scion Pharm Taiwan, Farmhispania Group, Chem Genix, Jeil Pharmaceutical, Zhuhai Rundu Pharma, Cipla, Brawn Laboratories, Nischem International, Zhejiang Hisun Pharmaceutical, Qilu Pharmaceutial

What are the Application segmentation covered in the Gefitinib API Market report?

Ans: The Applications covered in the Gefitinib API Market report are Gefitinib Tablets, Other

What are the Type segmentation covered in the Gefitinib API Market report?

Ans: The Types covered in the Gefitinib API Market report are Purity ≥ 98 %, Purity ≥ 99 %

1 Gefitinib API Market Overview
1.1 Product Definition
1.2 Gefitinib API by Type
1.2.1 Global Gefitinib API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Gefitinib API by Application
1.3.1 Global Gefitinib API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Gefitinib Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Gefitinib API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Gefitinib API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Gefitinib API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Gefitinib API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gefitinib API Production Market Share by Manufacturers (2020-2025)
2.2 Global Gefitinib API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Gefitinib API, Industry Ranking, 2023 VS 2024
2.4 Global Gefitinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Gefitinib API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Gefitinib API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gefitinib API, Product Offered and Application
2.8 Global Key Manufacturers of Gefitinib API, Date of Enter into This Industry
2.9 Gefitinib API Market Competitive Situation and Trends
2.9.1 Gefitinib API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gefitinib API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gefitinib API Production by Region
3.1 Global Gefitinib API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Gefitinib API Production Value by Region (2020-2031)
3.2.1 Global Gefitinib API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Gefitinib API by Region (2026-2031)
3.3 Global Gefitinib API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Gefitinib API Production Volume by Region (2020-2031)
3.4.1 Global Gefitinib API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Gefitinib API by Region (2026-2031)
3.5 Global Gefitinib API Market Price Analysis by Region (2020-2025)
3.6 Global Gefitinib API Production and Value, Year-over-Year Growth
3.6.1 North America Gefitinib API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Gefitinib API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Gefitinib API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Gefitinib API Production Value Estimates and Forecasts (2020-2031)
4 Gefitinib API Consumption by Region
4.1 Global Gefitinib API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Gefitinib API Consumption by Region (2020-2031)
4.2.1 Global Gefitinib API Consumption by Region (2020-2025)
4.2.2 Global Gefitinib API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Gefitinib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Gefitinib API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gefitinib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Gefitinib API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gefitinib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Gefitinib API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gefitinib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Gefitinib API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Gefitinib API Production by Type (2020-2031)
5.1.1 Global Gefitinib API Production by Type (2020-2025)
5.1.2 Global Gefitinib API Production by Type (2026-2031)
5.1.3 Global Gefitinib API Production Market Share by Type (2020-2031)
5.2 Global Gefitinib API Production Value by Type (2020-2031)
5.2.1 Global Gefitinib API Production Value by Type (2020-2025)
5.2.2 Global Gefitinib API Production Value by Type (2026-2031)
5.2.3 Global Gefitinib API Production Value Market Share by Type (2020-2031)
5.3 Global Gefitinib API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Gefitinib API Production by Application (2020-2031)
6.1.1 Global Gefitinib API Production by Application (2020-2025)
6.1.2 Global Gefitinib API Production by Application (2026-2031)
6.1.3 Global Gefitinib API Production Market Share by Application (2020-2031)
6.2 Global Gefitinib API Production Value by Application (2020-2031)
6.2.1 Global Gefitinib API Production Value by Application (2020-2025)
6.2.2 Global Gefitinib API Production Value by Application (2026-2031)
6.2.3 Global Gefitinib API Production Value Market Share by Application (2020-2031)
6.3 Global Gefitinib API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Scion Pharm Taiwan
7.1.1 Scion Pharm Taiwan Gefitinib API Company Information
7.1.2 Scion Pharm Taiwan Gefitinib API Product Portfolio
7.1.3 Scion Pharm Taiwan Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Scion Pharm Taiwan Main Business and Markets Served
7.1.5 Scion Pharm Taiwan Recent Developments/Updates
7.2 Farmhispania Group
7.2.1 Farmhispania Group Gefitinib API Company Information
7.2.2 Farmhispania Group Gefitinib API Product Portfolio
7.2.3 Farmhispania Group Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Farmhispania Group Main Business and Markets Served
7.2.5 Farmhispania Group Recent Developments/Updates
7.3 Chem Genix
7.3.1 Chem Genix Gefitinib API Company Information
7.3.2 Chem Genix Gefitinib API Product Portfolio
7.3.3 Chem Genix Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Chem Genix Main Business and Markets Served
7.3.5 Chem Genix Recent Developments/Updates
7.4 Jeil Pharmaceutical
7.4.1 Jeil Pharmaceutical Gefitinib API Company Information
7.4.2 Jeil Pharmaceutical Gefitinib API Product Portfolio
7.4.3 Jeil Pharmaceutical Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jeil Pharmaceutical Main Business and Markets Served
7.4.5 Jeil Pharmaceutical Recent Developments/Updates
7.5 Zhuhai Rundu Pharma
7.5.1 Zhuhai Rundu Pharma Gefitinib API Company Information
7.5.2 Zhuhai Rundu Pharma Gefitinib API Product Portfolio
7.5.3 Zhuhai Rundu Pharma Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Zhuhai Rundu Pharma Main Business and Markets Served
7.5.5 Zhuhai Rundu Pharma Recent Developments/Updates
7.6 Cipla
7.6.1 Cipla Gefitinib API Company Information
7.6.2 Cipla Gefitinib API Product Portfolio
7.6.3 Cipla Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Cipla Main Business and Markets Served
7.6.5 Cipla Recent Developments/Updates
7.7 Brawn Laboratories
7.7.1 Brawn Laboratories Gefitinib API Company Information
7.7.2 Brawn Laboratories Gefitinib API Product Portfolio
7.7.3 Brawn Laboratories Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Brawn Laboratories Main Business and Markets Served
7.7.5 Brawn Laboratories Recent Developments/Updates
7.8 Nischem International
7.8.1 Nischem International Gefitinib API Company Information
7.8.2 Nischem International Gefitinib API Product Portfolio
7.8.3 Nischem International Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Nischem International Main Business and Markets Served
7.8.5 Nischem International Recent Developments/Updates
7.9 Zhejiang Hisun Pharmaceutical
7.9.1 Zhejiang Hisun Pharmaceutical Gefitinib API Company Information
7.9.2 Zhejiang Hisun Pharmaceutical Gefitinib API Product Portfolio
7.9.3 Zhejiang Hisun Pharmaceutical Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Zhejiang Hisun Pharmaceutical Main Business and Markets Served
7.9.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.10 Qilu Pharmaceutial
7.10.1 Qilu Pharmaceutial Gefitinib API Company Information
7.10.2 Qilu Pharmaceutial Gefitinib API Product Portfolio
7.10.3 Qilu Pharmaceutial Gefitinib API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Qilu Pharmaceutial Main Business and Markets Served
7.10.5 Qilu Pharmaceutial Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gefitinib API Industry Chain Analysis
8.2 Gefitinib API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gefitinib API Production Mode & Process Analysis
8.4 Gefitinib API Sales and Marketing
8.4.1 Gefitinib API Sales Channels
8.4.2 Gefitinib API Distributors
8.5 Gefitinib API Customer Analysis
9 Gefitinib API Market Dynamics
9.1 Gefitinib API Industry Trends
9.2 Gefitinib API Market Drivers
9.3 Gefitinib API Market Challenges
9.4 Gefitinib API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Scion Pharm Taiwan
Farmhispania Group
Chem Genix
Jeil pharmaceutical
Zhuhai Rundu Pharma
Cipla Ltd
Brawn Laboratories
Nischem International
Zhejiang Hisun Pharmaceutical
Qilu Pharmaceutial
List of Tables
 Table 1. Global Gefitinib API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Gefitinib API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Gefitinib API Production Capacity (MT) by Manufacturers in 2024
 Table 4. Global Gefitinib API Production by Manufacturers (2020-2025) & (MT)
 Table 5. Global Gefitinib API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Gefitinib API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Gefitinib API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Gefitinib API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Gefitinib API as of 2024)
 Table 10. Global Market Gefitinib API Average Price by Manufacturers (USD/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Gefitinib API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Gefitinib API, Product Offered and Application
 Table 13. Global Key Manufacturers of Gefitinib API, Date of Enter into This Industry
 Table 14. Global Gefitinib API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gefitinib API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Gefitinib API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Gefitinib API Production Value Market Share by Region (2020-2025)
 Table 19. Global Gefitinib API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Gefitinib API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Gefitinib API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
 Table 22. Global Gefitinib API Production (MT) by Region (2020-2025)
 Table 23. Global Gefitinib API Production Market Share by Region (2020-2025)
 Table 24. Global Gefitinib API Production (MT) Forecast by Region (2026-2031)
 Table 25. Global Gefitinib API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Gefitinib API Market Average Price (USD/Kg) by Region (2020-2025)
 Table 27. Global Gefitinib API Market Average Price (USD/Kg) by Region (2026-2031)
 Table 28. Global Gefitinib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
 Table 29. Global Gefitinib API Consumption by Region (2020-2025) & (MT)
 Table 30. Global Gefitinib API Consumption Market Share by Region (2020-2025)
 Table 31. Global Gefitinib API Forecasted Consumption by Region (2026-2031) & (MT)
 Table 32. Global Gefitinib API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Gefitinib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 34. North America Gefitinib API Consumption by Country (2020-2025) & (MT)
 Table 35. North America Gefitinib API Consumption by Country (2026-2031) & (MT)
 Table 36. Europe Gefitinib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 37. Europe Gefitinib API Consumption by Country (2020-2025) & (MT)
 Table 38. Europe Gefitinib API Consumption by Country (2026-2031) & (MT)
 Table 39. Asia Pacific Gefitinib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
 Table 40. Asia Pacific Gefitinib API Consumption by Region (2020-2025) & (MT)
 Table 41. Asia Pacific Gefitinib API Consumption by Region (2026-2031) & (MT)
 Table 42. Latin America, Middle East & Africa Gefitinib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 43. Latin America, Middle East & Africa Gefitinib API Consumption by Country (2020-2025) & (MT)
 Table 44. Latin America, Middle East & Africa Gefitinib API Consumption by Country (2026-2031) & (MT)
 Table 45. Global Gefitinib API Production (MT) by Type (2020-2025)
 Table 46. Global Gefitinib API Production (MT) by Type (2026-2031)
 Table 47. Global Gefitinib API Production Market Share by Type (2020-2025)
 Table 48. Global Gefitinib API Production Market Share by Type (2026-2031)
 Table 49. Global Gefitinib API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Gefitinib API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Gefitinib API Production Value Market Share by Type (2020-2025)
 Table 52. Global Gefitinib API Production Value Market Share by Type (2026-2031)
 Table 53. Global Gefitinib API Price (USD/Kg) by Type (2020-2025)
 Table 54. Global Gefitinib API Price (USD/Kg) by Type (2026-2031)
 Table 55. Global Gefitinib API Production (MT) by Application (2020-2025)
 Table 56. Global Gefitinib API Production (MT) by Application (2026-2031)
 Table 57. Global Gefitinib API Production Market Share by Application (2020-2025)
 Table 58. Global Gefitinib API Production Market Share by Application (2026-2031)
 Table 59. Global Gefitinib API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Gefitinib API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Gefitinib API Production Value Market Share by Application (2020-2025)
 Table 62. Global Gefitinib API Production Value Market Share by Application (2026-2031)
 Table 63. Global Gefitinib API Price (USD/Kg) by Application (2020-2025)
 Table 64. Global Gefitinib API Price (USD/Kg) by Application (2026-2031)
 Table 65. Scion Pharm Taiwan Gefitinib API Company Information
 Table 66. Scion Pharm Taiwan Gefitinib API Specification and Application
 Table 67. Scion Pharm Taiwan Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 68. Scion Pharm Taiwan Main Business and Markets Served
 Table 69. Scion Pharm Taiwan Recent Developments/Updates
 Table 70. Farmhispania Group Gefitinib API Company Information
 Table 71. Farmhispania Group Gefitinib API Specification and Application
 Table 72. Farmhispania Group Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Farmhispania Group Main Business and Markets Served
 Table 74. Farmhispania Group Recent Developments/Updates
 Table 75. Chem Genix Gefitinib API Company Information
 Table 76. Chem Genix Gefitinib API Specification and Application
 Table 77. Chem Genix Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. Chem Genix Main Business and Markets Served
 Table 79. Chem Genix Recent Developments/Updates
 Table 80. Jeil Pharmaceutical Gefitinib API Company Information
 Table 81. Jeil Pharmaceutical Gefitinib API Specification and Application
 Table 82. Jeil Pharmaceutical Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Jeil Pharmaceutical Main Business and Markets Served
 Table 84. Jeil Pharmaceutical Recent Developments/Updates
 Table 85. Zhuhai Rundu Pharma Gefitinib API Company Information
 Table 86. Zhuhai Rundu Pharma Gefitinib API Specification and Application
 Table 87. Zhuhai Rundu Pharma Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Zhuhai Rundu Pharma Main Business and Markets Served
 Table 89. Zhuhai Rundu Pharma Recent Developments/Updates
 Table 90. Cipla Gefitinib API Company Information
 Table 91. Cipla Gefitinib API Specification and Application
 Table 92. Cipla Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Cipla Main Business and Markets Served
 Table 94. Cipla Recent Developments/Updates
 Table 95. Brawn Laboratories Gefitinib API Company Information
 Table 96. Brawn Laboratories Gefitinib API Specification and Application
 Table 97. Brawn Laboratories Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Brawn Laboratories Main Business and Markets Served
 Table 99. Brawn Laboratories Recent Developments/Updates
 Table 100. Nischem International Gefitinib API Company Information
 Table 101. Nischem International Gefitinib API Specification and Application
 Table 102. Nischem International Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Nischem International Main Business and Markets Served
 Table 104. Nischem International Recent Developments/Updates
 Table 105. Zhejiang Hisun Pharmaceutical Gefitinib API Company Information
 Table 106. Zhejiang Hisun Pharmaceutical Gefitinib API Specification and Application
 Table 107. Zhejiang Hisun Pharmaceutical Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Zhejiang Hisun Pharmaceutical Main Business and Markets Served
 Table 109. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 110. Qilu Pharmaceutial Gefitinib API Company Information
 Table 111. Qilu Pharmaceutial Gefitinib API Specification and Application
 Table 112. Qilu Pharmaceutial Gefitinib API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Qilu Pharmaceutial Main Business and Markets Served
 Table 114. Qilu Pharmaceutial Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Gefitinib API Distributors List
 Table 118. Gefitinib API Customers List
 Table 119. Gefitinib API Market Trends
 Table 120. Gefitinib API Market Drivers
 Table 121. Gefitinib API Market Challenges
 Table 122. Gefitinib API Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gefitinib API
 Figure 2. Global Gefitinib API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Gefitinib API Market Share by Type: 2024 VS 2031
 Figure 4. Purity ≥ 98 % Product Picture
 Figure 5. Purity ≥ 99 % Product Picture
 Figure 6. Global Gefitinib API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Gefitinib API Market Share by Application: 2024 VS 2031
 Figure 8. Gefitinib Tablets
 Figure 9. Other
 Figure 10. Global Gefitinib API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Gefitinib API Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Gefitinib API Production Capacity (MT) & (2020-2031)
 Figure 13. Global Gefitinib API Production (MT) & (2020-2031)
 Figure 14. Global Gefitinib API Average Price (USD/Kg) & (2020-2031)
 Figure 15. Gefitinib API Report Years Considered
 Figure 16. Gefitinib API Production Share by Manufacturers in 2024
 Figure 17. Global Gefitinib API Production Value Share by Manufacturers (2024)
 Figure 18. Gefitinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Gefitinib API Revenue in 2024
 Figure 20. Global Gefitinib API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Gefitinib API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Gefitinib API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 23. Global Gefitinib API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Gefitinib API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Gefitinib API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Gefitinib API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Gefitinib API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Gefitinib API Consumption by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 29. Global Gefitinib API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 31. North America Gefitinib API Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 33. Canada Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 34. Europe Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 35. Europe Gefitinib API Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 37. France Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 38. U.K. Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 39. Italy Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 40. Russia Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 41. Asia Pacific Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 42. Asia Pacific Gefitinib API Consumption Market Share by Region (2020-2031)
 Figure 43. China Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 44. Japan Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 45. South Korea Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 46. China Taiwan Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 47. Southeast Asia Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 48. India Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 49. Latin America, Middle East & Africa Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 50. Latin America, Middle East & Africa Gefitinib API Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 52. Brazil Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 53. Turkey Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 54. GCC Countries Gefitinib API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 55. Global Production Market Share of Gefitinib API by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Gefitinib API by Type (2020-2031)
 Figure 57. Global Gefitinib API Price (USD/Kg) by Type (2020-2031)
 Figure 58. Global Production Market Share of Gefitinib API by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Gefitinib API by Application (2020-2031)
 Figure 60. Global Gefitinib API Price (USD/Kg) by Application (2020-2031)
 Figure 61. Gefitinib API Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Gefitinib Market Research Report 2024
Gefitinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Capecitabine API Market Research Report 2024
Pharmaceutical Grade Gefitinib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erlotinib Hydrochloride API Market Research Report 2024
Global Tegafur API Market Research Report 2024
Global Oxaliplatin API Market Research Report 2024
Global Cisplatin API Market Research Report 2024
Global Bortezomib API Market Research Report 2024
Global Irinotecan Hydrochloride API Market Research Report 2024
Global Afatinib API Market Research Report 2024
Global Carboplatin API Market Research Report 2024
Bosutinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fluorouracil API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hydroxyurea API Market Research Report 2024
Global Platinum based Anticancer APIs Market Research Report 2024
Global Antitumor API Market Research Report 2024
Global Cefepime API Market Research Report 2024
Global Alectinib API Market Research Report 2025
Regorafenib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions